1. Home
  2. BLCO vs KNF Comparison

BLCO vs KNF Comparison

Compare BLCO & KNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • KNF
  • Stock Information
  • Founded
  • BLCO 1853
  • KNF 1917
  • Country
  • BLCO Canada
  • KNF United States
  • Employees
  • BLCO N/A
  • KNF N/A
  • Industry
  • BLCO Ophthalmic Goods
  • KNF
  • Sector
  • BLCO Health Care
  • KNF
  • Exchange
  • BLCO Nasdaq
  • KNF Nasdaq
  • Market Cap
  • BLCO 7.0B
  • KNF 6.0B
  • IPO Year
  • BLCO 2022
  • KNF N/A
  • Fundamental
  • Price
  • BLCO $18.02
  • KNF $105.71
  • Analyst Decision
  • BLCO Buy
  • KNF Strong Buy
  • Analyst Count
  • BLCO 12
  • KNF 6
  • Target Price
  • BLCO $20.91
  • KNF $99.20
  • AVG Volume (30 Days)
  • BLCO 524.8K
  • KNF 542.6K
  • Earning Date
  • BLCO 10-30-2024
  • KNF 02-13-2025
  • Dividend Yield
  • BLCO N/A
  • KNF N/A
  • EPS Growth
  • BLCO N/A
  • KNF 10.75
  • EPS
  • BLCO N/A
  • KNF 3.51
  • Revenue
  • BLCO $4,684,000,000.00
  • KNF $2,888,677,000.00
  • Revenue This Year
  • BLCO $17.39
  • KNF $3.27
  • Revenue Next Year
  • BLCO $6.18
  • KNF $6.33
  • P/E Ratio
  • BLCO N/A
  • KNF $30.10
  • Revenue Growth
  • BLCO 18.01
  • KNF 6.16
  • 52 Week Low
  • BLCO $13.16
  • KNF $61.50
  • 52 Week High
  • BLCO $21.69
  • KNF $108.39
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 36.81
  • KNF 57.24
  • Support Level
  • BLCO $17.71
  • KNF $99.98
  • Resistance Level
  • BLCO $18.99
  • KNF $108.39
  • Average True Range (ATR)
  • BLCO 0.52
  • KNF 3.97
  • MACD
  • BLCO -0.17
  • KNF -0.44
  • Stochastic Oscillator
  • BLCO 10.17
  • KNF 68.13

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About KNF Knife Riv Holding Co.

Knife River Holding Co formerly Knife River Corp provides construction materials and contracting services throughout the western, central, and southern United States. Knife River produces and delivers aggregates and markets crushed stone, sand, gravel, and related construction materials, including ready-mix concrete, asphalt, and other value-added products. It also distributes cement and asphalt oil. It has more than 1 billion tons of aggregate reserves, 110 ready-mix plants, 50 asphalt plants, and a combined 410,000 tons of liquid asphalt and cement storage. The company also performs integrated contracting services for most types of aggregate-related construction, including roads, freeways, bridges, residential properties, schools, shopping centers, office buildings, and industrial parks.

Share on Social Networks: